KRT14 and psoriasis: As reported before, homozygous K14-VEGF transgenic mice develop a psoriasis-like phenotype at 5–6 months old, including abnormal epidermal proliferation and differentiation, epidermal microabscesses, inflammatory infiltrates and so on[19].